Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × elacestrant × Clear all

NCT07209449 2026-03-18

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Phase 2 Recruiting

Recurrence, Endometrial Neoplasms